Cristiane Secca Da Silva

Title: Cristiane Secca Da Silva: Innovator in Antibody Research

Introduction

Cristiane Secca Da Silva is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of immunology through her innovative research and development of antibodies. Her work focuses on addressing autoimmune inflammatory diseases, which affect millions of individuals worldwide.

Latest Patents

Cristiane holds a patent for her invention titled "Anti-IL12RB1 antibodies." This patent encompasses isolated antibodies that specifically bind to IL12Rβ1. The invention is particularly noteworthy as it targets the beta 1 subunit of the receptors of IL-12 and IL-23. By blocking the signaling of inflammatory cytokines IL-12 and IL-23, these antibodies have the potential to be utilized in treating various autoimmune inflammatory diseases, including inflammatory bowel disease (IBD), rheumatoid arthritis (RA), and psoriasis. She has 1 patent to her name.

Career Highlights

Cristiane is affiliated with Washington University, where she conducts her research and collaborates with other experts in the field. Her work has garnered attention for its potential impact on therapeutic strategies for autoimmune conditions.

Collaborations

Cristiane collaborates with Marco Colonna, a fellow researcher, to advance their understanding of immune responses and develop innovative treatments.

Conclusion

Cristiane Secca Da Silva's contributions to antibody research exemplify the importance of innovation in addressing complex health challenges. Her work continues to pave the way for new therapeutic options for patients suffering from autoimmune diseases.